Ertapenem – Injection products
Recognized Interpretive Criteria
Additional FDA-identified interpretive criteria
|
Minimum Inhibitory |
Disk Diffusion |
||||
---|---|---|---|---|---|---|
Pathogen |
S |
I |
R |
S |
I |
R |
Enterobacteriaceae |
M100 standard is recognized |
|||||
Staphylococcus spp.a |
≤2 |
4 |
≥8 |
≥19 |
16-18 |
≤15 |
Haemophilus influenzae and |
M100 standard is recognized |
|||||
Streptococcus pneumoniae |
M100 standard is recognized |
- |
- |
- |
||
Streptococcus spp β- |
M100 standard is recognized |
- |
- |
- |
||
Streptococcus spp Viridans |
M100 standard is recognized |
- |
- |
- |
||
Anaerobes |
M100 standard is recognized |
- |
- |
- |
S = Susceptible; I = Intermediate; R = Resistant
a The standard regarding surrogate testing is recognized.